SCHEMBL7054256

SCHEMBL7054256

CCCC1(CC)CO1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28281978 0.89
SCHEMBL1710592 0.88
Phosphoric Acid SCHEMBL4952584 0.86
SCHEMBL28282096 0.85
SCHEMBL2411308 0.83
SCHEMBL22544221 0.83
SCHEMBL10339082 0.81 SIRT2 (0.36)
SCHEMBL6902692 0.81 SIRT2 (0.36)
SCHEMBL179683 0.81
SCHEMBL10871192 0.79 SIRT2 (0.39)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 26 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-117126151-A Glycolate oxidase inhibitors for use in the treatment of disease 生物马林药物股份有限公司 2023-11-28 CN disclosed
CN-117126152-A Glycolate oxidase inhibitors for use in the treatment of disease 生物马林药物股份有限公司 2023-11-28 CN disclosed
CN-117069712-A Glycolate oxidase inhibitors for use in the treatment of disease 生物马林药物股份有限公司 2023-11-17 CN disclosed
CN-117069713-A Glycolate oxidase inhibitors for use in the treatment of disease 生物马林药物股份有限公司 2023-11-17 CN disclosed
CN-117024420-A Glycolate oxidase inhibitors for use in the treatment of disease 生物马林药物股份有限公司 2023-11-10 CN disclosed
US-20230088214-A1 GLYCOLATE OXIDASE INHIBITORS FOR THE TREATMENT OF DISEASE BIOMARIN PHARMACEUTICAL INC. (US) 2023-03-23 US disclosed
US-20230089374-A1 GLYCOLATE OXIDASE INHIBITORS FOR THE TREATMENT OF DISEASE BIOMARIN PHARMACEUTICAL INC. (US) 2023-03-23 US disclosed
US-20230079913-A1 GLYCOLATE OXIDASE INHIBITORS FOR THE TREATMENT OF DISEASE BIOMARIN PHARMACEUTICAL INC. (US) 2023-03-16 US disclosed
US-11384055-B2 Glycolate oxidase inhibitors for the treatment of disease BIOMARIN PHARMACEUTICAL INC. (US) 2022-07-12 US disclosed
EP-3986863-A1 GLYCOLATE OXIDASE INHIBITORS FOR THE TREATMENT OF DISEASE BioMarin Pharmaceutical Inc. (US) 2022-04-27 EP disclosed
US-20030109744-A1 PROCESS FOR PREPARING 3-HYDROXYESTERS FROM EPOXIDE DERIVATIVES DAVY PROCESS TECHNOLOGY LTD. (GB) 2003-06-12 US disclosed
EP-1304321-A2 Process for preparing 3-Hydroxyesters from epoxide derivatives SAMSUNG ELECTRONICS CO., LTD. (KR) 2003-04-23 EP disclosed
CN-1412173-A Process for preparing 3-hydroxy ester from epoxide derivative SAMSUNG ELECTRONICS CO LTD (KR) 2003-04-23 CN disclosed
US-6465680-B2 USING COBALT CATALYST AND PROMOTER SAMSUNG ELECTRONICS CO., LTD. (KR) 2002-10-15 US disclosed
US-20020035290-A1 Process for preparing malonate derivatives or beta -keto esters from epoxide derivatives SAMSUNG ELECTRONICS CO., LTD. 2002-03-21 US disclosed
CN-1330064-A Method for producing malonate derivative or beta-ket-acid ester by epoxide derivative SAMSUNG ELECTRONICS CO LTD (KR) 2002-01-09 CN disclosed
US-5466838-A Catalytic reaction of olefin with oxygen in the presence of aldehyde SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 1995-11-14 US disclosed
EP-0540009-B1 Process for producing epoxides SUMITOMO CHEMICAL CO (JP) 1995-08-30 EP disclosed
US-5367087-A Process for producing epoxide SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 1994-11-22 US disclosed
EP-0540009-A1 Process for producing epoxides SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 1993-05-05 EP disclosed